| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/02/2000 | CA2352495A1 Human semaphorin 6a-1 (sema6a-a), a gene involved in neuronal development and regeneration mechanisms during apoptosis, and its use as a potential drug target |
| 06/02/2000 | CA2352486A1 Methods and reagents for increasing proliferative capacity and preventing replicative senescence |
| 06/02/2000 | CA2352477A1 Compositions comprising angiostatin and kringle 5 region of plasminogen and methods of use thereof |
| 06/02/2000 | CA2352458A1 Compositions and methods using lactadherin or variants thereof |
| 06/02/2000 | CA2352456A1 Primer extension methods utilizing donor and acceptor molecules for detecting nucleic acids |
| 06/02/2000 | CA2352347A1 Novel polypeptide |
| 06/02/2000 | CA2352279A1 Amphiphilic polyamine compounds |
| 06/02/2000 | CA2352084A1 Immunostimulatory dna |
| 06/02/2000 | CA2352083A1 Zace1: a human metalloenzyme |
| 06/02/2000 | CA2352042A1 Multiplex amplification of short tandem repeat loci |
| 06/02/2000 | CA2351943A1 Stabilisation of milk from transgenic animals |
| 06/02/2000 | CA2351880A1 Dna molecules encoding hg51, a g-protein-coupled receptor |
| 06/02/2000 | CA2351872A1 Use of activated trap for screening for specific inhibitor of trap and method for aiding in the identification of a compound for use in the treatment of diseases or degenerative conditions resulting in increased bone resorption |
| 06/02/2000 | CA2351741A1 Vectors for gene mutagenesis and gene discovery by gene trapping |
| 06/02/2000 | CA2351737A1 Efficient methods for producing antimicrobial cationic peptides in host cells |
| 06/02/2000 | CA2351736A1 Methods of identifying antigen gene sequences |
| 06/02/2000 | CA2351733A1 Nf-kb activation inhibitors, and their pharmaceutical uses |
| 06/02/2000 | CA2351630A1 Vector |
| 06/02/2000 | CA2351567A1 Mutation of the parkin gene, compositions, methods and uses |
| 06/02/2000 | CA2351419A1 Method and device for automated chromophore-assisted laser/light inactivation (cali) |
| 06/02/2000 | CA2351365A1 Potassium channel interactors and uses therefor |
| 06/02/2000 | CA2351361A1 Gtpase associated proteins |
| 06/02/2000 | CA2351311A1 Uses for eph receptor antagonists and agonists to treat vascular disorders |
| 06/02/2000 | CA2351143A1 Method for identifying cytosine methylation patterns in genomic dna |
| 06/02/2000 | CA2350779A1 Methods for the preparation of nucleic acid and polypeptide libraries and uses thereof |
| 06/02/2000 | CA2350756A1 Methods and apparatus for flow-through hybridization |
| 06/02/2000 | CA2350749A1 Immortalized brain endothelial cells |
| 06/02/2000 | CA2350399A1 Regulatory sequences useful for gene expression in plant embryo tissue |
| 06/02/2000 | CA2350395A1 Nucleotide and protein sequences of nogo genes and methods based thereon |
| 06/02/2000 | CA2350336A1 Maize rad23 genes and uses thereof |
| 06/02/2000 | CA2350189A1 Recombinant methods and materials for producing epothilone and epothilone derivatives |
| 06/02/2000 | CA2349337A1 Prion protein standard and method of making same |
| 06/02/2000 | CA2347850A1 Regulatory protein pke#83 from human keratinocytes |
| 06/02/2000 | CA2347700A1 Antibodies to peptides that target git receptors and related methods |
| 06/02/2000 | CA2345157A1 Method for electrochemically detecting nucleic acid oligomer hybrids |
| 06/02/2000 | CA2318401A1 Nucleic acid fragments, recombinant vector containing the same and method for promoting the expression of structural gene by using the same |
| 06/02/2000 | CA2318340A1 Process for processing sucrose into glucose |
| 06/02/2000 | CA2291453A1 Dna-constructs of blood clotting factors and p-selectin |
| 05/31/2000 | EP1004873A1 Method and apparatus for identifying the function of biological molecules |
| 05/31/2000 | EP1004677A1 Method for the direct, exponential amplification and sequencing of DNA molecules and its application |
| 05/31/2000 | EP1004675A2 Methods of screening for nucleoside analogs that are incorporated by HIV reverse transcriptase and cause incorrect base pairing |
| 05/31/2000 | EP1004672A2 Thermostable protein having deoxyribonuclease activity |
| 05/31/2000 | EP1004670A2 Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents |
| 05/31/2000 | EP1004669A1 Novel differentiation inhibitor |
| 05/31/2000 | EP1004668A2 Regulatory protein pKe 83 derived from human keratinocytes |
| 05/31/2000 | EP1004667A1 Cell cycle-regulating proteins |
| 05/31/2000 | EP1004666A1 Protein having pdz domain sequence |
| 05/31/2000 | EP1004665A1 Scavenger receptor-like proteins |
| 05/31/2000 | EP1004664A1 Compositions and methods using lactadherin or variants thereof |
| 05/31/2000 | EP1004663A1 Process for producing purine nucleosides via fermentation |
| 05/31/2000 | EP1004596A1 1(3)mbt PROTEIN, POLYNUCLEOTIDE CODING FOR SAID PROTEIN, ANTISENSE POLYNUCLEOTIDE THEREOF, AND ANTIBODY RECOGNIZING SAID PROTEIN |
| 05/31/2000 | EP1004319A1 Remedies for solid tumor containing wilms' tumor gene (wt1) expression inhibitors |
| 05/31/2000 | EP1004313A1 Cachexia remedy |
| 05/31/2000 | EP1004238A1 Transgenic mammals |
| 05/31/2000 | EP1004056A1 Multi parameter scanner |
| 05/31/2000 | EP1003917A1 Method and kit for hla class i typing dna |
| 05/31/2000 | EP1003916A1 Antisense oligonucleotide compositions and methods for the modulation of jnk proteins |
| 05/31/2000 | EP1003913A2 A method of removing nucleic acid contamination in amplification reactions |
| 05/31/2000 | EP1003911A1 Method for the identification of synthetic cell- or tissue-specific transcriptional regulatory regions |
| 05/31/2000 | EP1003910A1 Multiple functionalities within an array element and uses thereof |
| 05/31/2000 | EP1003908A1 Nucleic acid archiving |
| 05/31/2000 | EP1003899A1 Vectors and methods for providing cells with additional nucleic acid material integrated in the genome of said cells |
| 05/31/2000 | EP1003898A1 Integrin-targeting vectors having transfection activity |
| 05/31/2000 | EP1003897A1 Complexes for transporting nucleic acid into eukaryotic higher-cells |
| 05/31/2000 | EP1003896A1 Coat-protein-modified baculovirus vector for gene therapy |
| 05/31/2000 | EP1003895A2 Cloning vectors for producing adenoviral minimal viruses |
| 05/31/2000 | EP1003894A2 Lentiviral vectors |
| 05/31/2000 | EP1003893A1 Complementation trap |
| 05/31/2000 | EP1003892A2 Inhibition of unwanted hormone action in plants |
| 05/31/2000 | EP1003891A1 Specific gene activation by chimeric gal4 transcription factors in stable transgenic plants |
| 05/31/2000 | EP1003890A2 Plant fatty acid synthases and use in improved methods for production of medium-chain fatty acids |
| 05/31/2000 | EP1003889A1 NOVEL $i(PICHIA PASTORIS) GENE SEQUENCES AND METHODS FOR THEIR USE |
| 05/31/2000 | EP1003888A2 Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis |
| 05/31/2000 | EP1003887A1 Use of a virus dna as promoter |
| 05/31/2000 | EP1003886A1 Chimeric transcriptional activators and compositions and uses related thereto |
| 05/31/2000 | EP1003885A1 Microorganism and esterase obtained therefrom |
| 05/31/2000 | EP1003884A1 Engineering plant thioesterases and disclosure of plant thioesterases having novel substrate specificity |
| 05/31/2000 | EP1003883A1 HISTIDINE KINASE TWO-COMPONENT IN $i(CANDIDA ALBICANS) |
| 05/31/2000 | EP1003882A1 Diacylglycerol acyl transferase proteins |
| 05/31/2000 | EP1003881A2 Transformed yeast strains and their use for the production of monoterminal and diterminal aliphatic carboxylates |
| 05/31/2000 | EP1003880A2 Human ubiquitin carrier protein e2-like protein and cyclin b-like protein |
| 05/31/2000 | EP1003879A1 Antigen constructs useful in the detection and differentiation of antibodies to hiv |
| 05/31/2000 | EP1003878A2 Hiv-1 group o antigens and uses thereof |
| 05/31/2000 | EP1003877A2 Papilloma virus, agents for the detection thereof and for the therapy of the diseases caused by said virus |
| 05/31/2000 | EP1003876A2 Pesticidal bacillus thuringiensis strains |
| 05/31/2000 | EP1003875A1 Group a streptococcal vaccines |
| 05/31/2000 | EP1003874A1 Neisseria lactoferrin binding protein |
| 05/31/2000 | EP1003873A1 Increasing production of proteins in gram-positive microorganisms |
| 05/31/2000 | EP1003872A1 Increasing production of proteins in gram-positive microorganisms |
| 05/31/2000 | EP1003871A2 Trichoderma reesei swollenin protein and encoding dna sequence |
| 05/31/2000 | EP1003870A1 A polynucleotide functionally coding for the lhp protein from mycobacterium tuberculosis, its biologically active derivative fragments, as well as methods using the same |
| 05/31/2000 | EP1003869A1 Production of polyunsaturated fatty acids by expression of polyketide-like synthesis genes in plants |
| 05/31/2000 | EP1003868A1 Genetic control of plant growth and development |
| 05/31/2000 | EP1003867A1 Tolerance of trichothecene mycotoxins in plants and animals through the modification of the ribosomal protein l3 gene |
| 05/31/2000 | EP1003866A1 Method for identifying and locating expressed epil peptides, coded by the insl4 gene and their uses |
| 05/31/2000 | EP1003865A2 Mutation within the connexin 26 gene responsible for prelingual non-syndromic deafness and method of detection |
| 05/31/2000 | EP1003864A1 Trail receptors, nucleic acids encoding the same, and methods of use thereof |
| 05/31/2000 | EP1003863A1 Mammalian cytokine receptor-11 |
| 05/31/2000 | EP1003862A1 Human longevity-assurance protein homologs |
| 05/31/2000 | EP1003861A2 Mammalian cell membrane proteins; related reagents |